Can a detailed nuchal translucency (NT) scan detect enlarged ventricles and heart defects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Detecting Enlarged Ventricles and Heart Defects During NT Scan

Yes, a detailed nuchal translucency (NT) scan can detect enlarged ventricles and heart defects, though with varying sensitivity depending on gestational age and the expertise of the center performing the scan. 1

Detection of Heart Defects During NT Scan

Capabilities of NT Scan for Heart Defect Detection:

  • First trimester fetal echocardiography performed at 11-14 weeks can identify 50-65% of major heart anomalies in low and high-risk patients respectively 1
  • At a nuchal translucency threshold of ≥3 mm (99th percentile), approximately 1% of patients will require standard second trimester fetal echocardiography 1
  • Early cardiac evaluation is possible at 13-14 weeks in over 90% of cases 1

Types of Heart Defects Detectable:

  • Approximately half of hypoplastic left heart and atrioventricular septal defects can be detected at 11-14 weeks 1
  • Less than a quarter of conotruncal abnormalities are detectable at this early stage 1
  • The risk of congenital heart disease is 6.6 times higher in fetuses with increased NT compared to those with normal NT 2

Limitations and Follow-up:

  • Detection rates vary according to the experience of the center, population studied, and type of defect present 1
  • First trimester pitfalls can result in both false-positive and missed diagnoses 1
  • A repeat fetal echocardiogram is still recommended in the second trimester (18-22 weeks) for pregnancies with increased nuchal translucency 1

Detection of Enlarged Ventricles (Brain Abnormalities)

Capabilities for Brain Abnormality Detection:

  • The NT scan can provide an opportunity to screen for structural fetal anomalies when viewing within the sagittal planes of the fetus 3
  • Brain abnormalities such as acrania, holoprosencephaly, Dandy-Walker syndrome, and cerebellar agenesis can be detected during NT examination 3
  • Early fetal anatomic survey may be performed at the time an increased NT is identified, providing opportunity for early detection of major malformations affecting the brain 1

Limitations for Brain Abnormality Detection:

  • The sensitivity of ultrasound at 11-14 weeks for detection of congenital anomalies is only about 50% compared to 75% at 18-22 weeks 1
  • Detailed assessment of brain structures is more challenging in the first trimester due to ongoing fetal development

Recommendations for Optimal Detection

When Increased NT is Detected:

  • When NT measures ≥3 mm, genetic counseling and diagnostic testing should be promptly offered 1
  • An early fetal anatomic survey should be performed to detect major malformations affecting the brain, heart, abdominal wall, and limbs 1
  • A detailed second trimester anatomic survey and fetal echocardiogram should be performed regardless of genetic testing results 1

Improving Detection Rates:

  • Addition of simple cardiac scan to the combined first trimester screening parameters improves detection of major congenital heart defects 4
  • Assessment of ductus venosus blood flow and tricuspid regurgitation can enhance detection of heart defects 4
  • In experienced centers, early fetal echocardiography has a high degree of accuracy 5

The detection of enlarged ventricles and heart defects during NT scan is possible but should be confirmed with follow-up detailed anatomy scan at 18-22 weeks for comprehensive assessment, as this remains the gold standard for structural anomaly detection.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.